PMID- 37217016
OWN - NLM
STAT- MEDLINE
DCOM- 20230619
LR  - 20230619
IS  - 1872-8227 (Electronic)
IS  - 0168-8227 (Linking)
VI  - 201
DP  - 2023 Jul
TI  - Effectiveness of telemonitoring intervention on glycaemic control in patients 
      with type 2 diabetes mellitus: A systematic review and meta-analysis.
PG  - 110727
LID - S0168-8227(23)00490-4 [pii]
LID - 10.1016/j.diabres.2023.110727 [doi]
AB  - BACKGROUND: Type 2 diabetes mellitus (T2DM) is a rising global health concern 
      that requires long-term treatment and close monitoring. Telemonitoring has been 
      shown to be a promising tool to facilitate patient-physician interaction and 
      improve glycaemic control. METHOD: Randomised controlled trials (RCT) of 
      telemonitoring in T2DM published between 1990 and 2021 were searched through 
      multiple electronic databases. The primary outcome variables included HbA1c and 
      fasting blood glucose (FBG), and BMI was a secondary outcome variable. RESULTS: 
      Thirty RCT with a total of 4,678 participants were included in this study. 
      Twenty-six studies reported on HbA1c, which was shown to be significantly lower 
      in participants on telemonitoring when compared to conventional care. Ten studies 
      investigated FBG which collectively showed no statistically significant 
      difference. Subgroup analysis demonstrated the effect of telemonitoring on 
      glycaemic control is influenced by a range of factors concerning system 
      practicality, user engagement, patient characteristics and disease education. 
      CONCLUSION: Telemonitoring exhibited a great potential to improve T2DM 
      management. Several technical features and patient factors may influence the 
      effectiveness of telemonitoring. Further studies are needed to verify the 
      findings and address limitations before its implementation into routine practice.
CI  - Copyright (c) 2023 Elsevier B.V. All rights reserved.
FAU - Cai, Jinxuan
AU  - Cai J
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia. 
      Electronic address: jinxuan.cai@griffithuni.edu.au.
FAU - Xu, Huaying
AU  - Xu H
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia. 
      Electronic address: huaying.xu@griffithuni.edu.au.
FAU - Jiang, Stephen
AU  - Jiang S
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia. 
      Electronic address: stephen.jiang@griffithuni.edu.au.
FAU - Sung, Jerry
AU  - Sung J
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia. 
      Electronic address: jerry.sung@griffithuni.edu.au.
FAU - Sawhney, Rakshat
AU  - Sawhney R
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia. 
      Electronic address: rakshat.sawhney@griffithuni.edu.au.
FAU - Broadley, Simon
AU  - Broadley S
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia; Menzies 
      Health Institute Queensland, Griffith University, Q4215, Australia; Department of 
      Neurology, Gold Coast University Hospital, Q4222, Australia. Electronic address: 
      simon.broadley@griffith.edu.au.
FAU - Sun, Jing
AU  - Sun J
AD  - School of Medicine and Dentistry, Griffith University, Q4215, Australia; Menzies 
      Health Institute Queensland, Griffith University, Q4215, Australia; Institute for 
      Integrated and Intelligent System, Griffith University, Q4222, Australia. 
      Electronic address: j.sun@griffith.edu.au.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PT  - Systematic Review
DEP - 20230520
PL  - Ireland
TA  - Diabetes Res Clin Pract
JT  - Diabetes research and clinical practice
JID - 8508335
RN  - 0 (Glycated Hemoglobin)
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Humans
MH  - Glycated Hemoglobin
MH  - *Glycemic Control
MH  - *Diabetes Mellitus, Type 2/complications
MH  - Blood Glucose
OTO - NOTNLM
OT  - BMI
OT  - Fasting blood glucose
OT  - HbA1c
OT  - Telemonitoring
OT  - Type 2 diabetes mellitus
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2023/05/23 01:06
MHDA- 2023/06/19 13:08
CRDT- 2023/05/22 19:19
PHST- 2022/04/18 00:00 [received]
PHST- 2023/02/18 00:00 [revised]
PHST- 2023/05/18 00:00 [accepted]
PHST- 2023/06/19 13:08 [medline]
PHST- 2023/05/23 01:06 [pubmed]
PHST- 2023/05/22 19:19 [entrez]
AID - S0168-8227(23)00490-4 [pii]
AID - 10.1016/j.diabres.2023.110727 [doi]
PST - ppublish
SO  - Diabetes Res Clin Pract. 2023 Jul;201:110727. doi: 10.1016/j.diabres.2023.110727. 
      Epub 2023 May 20.